[HTML][HTML] Reappraisal of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: a systematic review and meta-analysis
Background: Recent observational studies have compared effectiveness and safety profiles
between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in patients with …
between non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in patients with …
Adherence and clinical outcomes for twice-daily versus once-daily dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: Is dosing …
HJ Hwang, IS Sohn, ES Jin, YJ Bae - PLoS One, 2023 - journals.plos.org
Background Twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs)
may reduce drug adherence compared with once-daily dosing of NOACs in patients with …
may reduce drug adherence compared with once-daily dosing of NOACs in patients with …
Association between hemoglobin variability and incidence of hypertension over 40 years: a Korean national cohort study
Hemoglobin level determines blood viscosity and as hemoglobin level rises, blood pressure
rises. However, hemoglobin level in individuals is not fixed and change in hemoglobin is …
rises. However, hemoglobin level in individuals is not fixed and change in hemoglobin is …
Gastrointestinal bleeding on oral anticoagulation: what is currently known
Gastrointestinal bleeding (GIB) is the most common type of bleeding occurring in patients on
oral anticoagulation. A meta-analysis of the landmark randomized controlled trials (RCTs) …
oral anticoagulation. A meta-analysis of the landmark randomized controlled trials (RCTs) …
Temporal trends of emergency department visits of patients with atrial fibrillation: a nationwide population-based study
We aimed to describe temporal trends in emergency department (ED) visits of patients with
atrial fibrillation (AF) over 12 years. A repeated cross-sectional analysis of ED visits in AF …
atrial fibrillation (AF) over 12 years. A repeated cross-sectional analysis of ED visits in AF …
[HTML][HTML] The safety and efficacy of the use of oral anticoagulant medications in patients with diabetes mellitus: A systematic review
Aims Diabetes mellitus (DM) and atrial fibrillation (AF) commonly co-exist. Oral
anticoagulants (OACs) are widely used in patients with DM. This review aims to summarise …
anticoagulants (OACs) are widely used in patients with DM. This review aims to summarise …
[HTML][HTML] Update on association between exposure to renin-angiotensin-aldosterone system inhibitors and coronavirus disease 2019 in South Korea
Methods We performed a case-control study that utilized up-to-date data on the South
Korean population provided by the Korean National Health Insurance System. Of the 62,909 …
Korean population provided by the Korean National Health Insurance System. Of the 62,909 …
Real-world evaluation of perception, convenience and anticoagulant treatment satisfaction of patients with atrial fibrillation switched from long-term vitamin K …
EK Choi, YS Lee, AKC Chern, P Jiampo… - Open …, 2020 - openheart.bmj.com
Background and purpose Real-world data about treatment convenience and satisfaction in
Asian non-valvular atrial fibrillation (NVAF) patients after switching from vitamin K …
Asian non-valvular atrial fibrillation (NVAF) patients after switching from vitamin K …
[HTML][HTML] Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
WJ Li, P Archontakis-Barakakis… - World Journal of …, 2021 - ncbi.nlm.nih.gov
BACKGROUND Most of the randomized clinical trials that led to the wide use of non-vitamin
K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation (AF) …
K antagonist oral anticoagulants for stroke prevention in patients with atrial fibrillation (AF) …
Effectiveness and safety of non‐vitamin K antagonist oral anticoagulants in patients with non‐valvular atrial fibrillation: A nationwide, population‐based study in Korea
Background To compare the risk of stroke/systemic embolism (S/SE) and major bleeding
(MB) between non‐vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial …
(MB) between non‐vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial …